ArticleObesity surgery2022

Risk of Harm from Use of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Patients Pre or Post Bariatric Surgery.

Mitesh Sharma et al.PubMed ↗Publisher ↗

No numbers read from the abstract.